Abel Hall LLC’s P3 Health Partners PIII Stock Holding History

Abel Hall LLC’s Portfolio PIII Stock Details PIII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-299	Closed	-$6.73K	–	168
2024 Q2	$6.73K	Buy	+299	New	+$8.93K	﹤0.01%	142

Other funds holding PIII

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AWC

Abundance Wealth Counselors State College, Pennsylvania $1.54B AUM 31.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Abel Hall LLC's PIII Position: Q3 2024 in Review

Abel Hall LLC sold out of P3 Health Partners (PIII) in Q3 2024, closing a stake of 299 shares — an estimated $6.73K sold.

Abel Hall LLC first reported a position in PIII in Q2 2024 and held it in 1 quarter. The position peaked at $6.73K in Q2 2024. 46 funds tracked by Wall St. Rank hold PIII as of Q3 2024.

Abel Hall LLC reported no remaining P3 Health Partners position as of Q3 2024 after selling out during the quarter.
Abel Hall LLC sold 299 P3 Health Partners shares in Q3 2024, an estimated $6.73K.
Abel Hall LLC first reported a position in P3 Health Partners in Q2 2024 and held it in 1 quarter.
Abel Hall LLC's P3 Health Partners position peaked at $6.73K in Q2 2024.
46 funds tracked by Wall St. Rank held P3 Health Partners as of Q3 2024.

Based on Abel Hall LLC's 13F filing for Q3 2024, filed 15 Nov 2024.